CMIC Holdings Co Ltd
TSE:2309

Watchlist Manager
CMIC Holdings Co Ltd Logo
CMIC Holdings Co Ltd
TSE:2309
Watchlist
Price: 999 999.9999 JPY 37 893.92% Market Closed
Market Cap: 47.6B JPY
Have any thoughts about
CMIC Holdings Co Ltd?
Write Note

CMIC Holdings Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CMIC Holdings Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
CMIC Holdings Co Ltd
TSE:2309
Other Long-Term Assets
ÂĄ8.9B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
11%
C
Chiome Bioscience Inc
TSE:4583
Other Long-Term Assets
ÂĄ134.4m
CAGR 3-Years
4%
CAGR 5-Years
11%
CAGR 10-Years
6%
Medinet Co Ltd
TSE:2370
Other Long-Term Assets
-ÂĄ457.7m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
CellSource Co Ltd
TSE:4880
Other Long-Term Assets
ÂĄ459.8m
CAGR 3-Years
70%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Other Long-Term Assets
ÂĄ1.4B
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
16%
WDB coco Co Ltd
TSE:7079
Other Long-Term Assets
ÂĄ223.3m
CAGR 3-Years
14%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

CMIC Holdings Co Ltd
Glance View

Market Cap
47.6B JPY
Industry
Life Sciences Tools & Services

CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Intrinsic Value
1 111 603.22 JPY
Undervaluation 10%
Intrinsic Value
Price

See Also

What is CMIC Holdings Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
8.9B JPY

Based on the financial report for Dec 31, 2023, CMIC Holdings Co Ltd's Other Long-Term Assets amounts to 8.9B JPY.

What is CMIC Holdings Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
11%

Over the last year, the Other Long-Term Assets growth was -23%. The average annual Other Long-Term Assets growth rates for CMIC Holdings Co Ltd have been 14% over the past three years , 10% over the past five years , and 11% over the past ten years .

Back to Top